DiCE Molecules designs and develops innovative therapies in immunology for patients with debilitating disease. Seeking to create a future where convenient oral medicines with biologic-like efficacy are available to patients with serious medical conditions, they are developing oral alternatives to medicines currently limited to injectable forms. 

Biotechnology

DiCE Molecules

J. Kevin Judice

Tania Santiago

Christian Puccetti

Colette Cochran

Khushbu Patel

Paul Fatheree

Nico Ghilardi

Tim Lu

Nick Shah

Scott Robertson

John Jacobsen

Clinical Operations and Management

Leadership Team

Development and Drug Discovery

Chemistry Team

Operations and IT Team

Teams at DiCE Molecules

Clinical Operations and Management

Leadership Team

Development and Drug Discovery

Chemistry Team

Operations and IT Team